Literature DB >> 9296427

The effect of priming with vecuronium and rocuronium on young and elderly patients.

L Aziz1, S M Jahangir, S N Choudhury, K Rahman, Y Ohta, M Hirakawa.   

Abstract

UNLABELLED: The priming principle consists of administering a subparalyzing dose of nondepolarizing neuromuscular blocking drug 3-6 min before giving a second dose for tracheal intubation. This study was performed to observe the effects of priming doses of vecuronium and rocuronium on pulmonary function tests and muscular weaknesses in young (25-35 yr of age) and elderly (65-73 yr of age) patients. Ten young and 10 elderly patients were each placed in vecuronium and rocuronium groups. Oxygen saturation and train-of-four (TOF) ratio were determined, and pulmonary function tests were performed. Then 20% of the 95% effective dose (ED95) of the muscle relaxants was given intravenously. All tests were performed again 4 min after vecuronium and 3 min after rocuronium. Other signs of muscular weaknesses were also recorded. Elderly patients showed more signs of muscle weakness in both groups. The TOF ratio was 0.77 and 0.79 in the elderly rocuronium and vecuronium groups, respectively, and 0.89 and 0.90 in the young rocuronium and vecuronium groups, respectively. Dynamic spirometry revealed decreases in forced expiratory volume in 1 s and forced vital capacity in both groups, and no significant changes in peak expiratory flow rate. The expiratory reserve volume was reduced more in the elderly groups. Oxygen saturation decreased in both groups. We conclude that oxygen saturation, pulmonary function, and muscle strength decrease more in the elderly than in their younger counterparts from priming doses of vecuronium or rocuronium. IMPLICATIONS: The priming principle consists of giving a subparalyzing dose of muscle relaxant 3-6 min before giving a second dose for tracheal intubation. We found that priming doses of vecuronium and rocuronium produced greater decreases in oxygen saturation and pulmonary function in the elderly (aged 65-73 yr) than their younger (aged 25-35 yr) counterparts. Priming may not be a safe approach in elderly patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9296427     DOI: 10.1097/00000539-199709000-00032

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

Review 1.  Newer neuromuscular blocking agents: how do they compare with established agents?

Authors:  H J Sparr; T M Beaufort; T Fuchs-Buder
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Swallowing action immediately before intravenous fentanyl at induction of anesthesia prevents fentanyl-induced coughing: a randomized controlled study.

Authors:  Saori Sako; Shoji Tokunaga; Masanori Tsukamoto; Jun Yoshino; Naoyuki Fujimura; Takeshi Yokoyama
Journal:  J Anesth       Date:  2017-01-03       Impact factor: 2.078

3.  Rocuronium priming for tracheal intubation in COVID-19 patients.

Authors:  H Hoshijima; H Nagasaka; M Ozaki; K Komiyama; T Mieda; C Nakamura; K Doi
Journal:  Anaesth Rep       Date:  2020-08-03

4.  [Priming technique with cisatracurium Onset time at the laryngeal muscles].

Authors:  J Schmidt; S Albrecht; N Petterich; J Fechner; P Klein; A Irouschek
Journal:  Anaesthesist       Date:  2007-10       Impact factor: 1.041

5.  Priming with rocuronium or vecuronium prevents remifentanil-mediated muscle rigidity and difficult ventilation.

Authors:  Junya Nakada; Masao Nishira; Renko Hosoda; Kazumi Funaki; Shyunsaku Takahashi; Tatsuya Matsura; Yoshimi Inagaki
Journal:  J Anesth       Date:  2009-08-14       Impact factor: 2.078

6.  Onset and effectiveness of rocuronium for rapid onset of paralysis in patients with major burns: priming or large bolus.

Authors:  T-H Han; J A J Martyn
Journal:  Br J Anaesth       Date:  2008-11-21       Impact factor: 9.166

7.  Comparison of intubating conditions between rocuronium with priming and without priming: Randomized and double-blind study.

Authors:  M Hanumantha Rao; Andal Venkatraman; R Mallleswari
Journal:  Indian J Anaesth       Date:  2011-09

8.  Subparalyzing Doses of Rocuronium Reduce Muscular Endurance without Detectable Effect on Single Twitch Height in Awake Subjects.

Authors:  Jan Gelberg; Peter Bentzer; David Grubb
Journal:  Anesthesiol Res Pract       Date:  2019-05-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.